By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selecta Biosciences, Inc. 

480 Arsenal Street
Building One
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-1400 Fax: 617-924-3454


Company News
Selecta (SELB) Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine And Celiac Disease Treatment 2/6/2017 7:58:09 AM
Massachusetts' Selecta (SELB) Wrangles $890 Million+ R&D Deal Out of Spark Therapeutics (ONCE) 12/5/2016 5:44:25 AM
Selecta (SELB) Collaborators At The National Cancer Institute Present Preclinical Data Showing SVP-Rapamycin Application To Cancer Therapy 10/31/2016 9:06:20 AM
Selecta (SELB) Announces Second Quarter 2016 Financial Results And Provides Corporate Update 8/9/2016 8:36:32 AM
Selecta (SELB) Announces Gene Therapy Programs For Two Rare Genetic Metabolic Disorders 7/19/2016 9:20:34 AM
With Selecta (SELB)'s $70 Million IPO, Mass Biotechs Raised a Total of $376 Million This Year 6/24/2016 6:32:13 AM
Selecta's IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year 6/20/2016 6:38:33 AM
Selecta Obtains Exclusive License To Proprietary Gene Therapy Vector From Massachusetts Eye And Ear 5/19/2016 11:11:31 AM
Selecta Continues To Successfully Advance Pipeline Of Novel Immunotherapeutic Candidates 10/16/2015 10:43:16 AM
Selecta Appoints Earl E. Sands, MD, As Chief Medical Officer 9/8/2015 1:08:18 PM